Burden of lung cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030

Yuan Fang,Zhen Li,Hui Chen,Tongchao Zhang,Xiaolin Yin,Jinyu Man,Xiaorong Yang,Ming Lu

DOI: https://doi.org/10.1007/s00432-022-04217-5

2022-07-29

Journal of Cancer Research and Clinical Oncology

Abstract:ObjectiveThis study aimed to identify and project the epidemiological trends and the burden of lung cancer in China.MethodsWe extracted incidence, mortality, disability-adjusted life-years (DALYs) and age-standardized rates of lung cancer in China, between 1990 and 2019, from the Global Burden of Disease Study (2019). The estimated annual percentage change (EAPC) was applied to quantify the trends of lung cancer burden. Furthermore, we used the Bayesian age-period-cohort model to project the incidence and mortality in the next decade.ResultsFrom 1990 to 2019, the estimated national number of lung cancer incident cases increased by 224.0% to 832,920, deaths increased by 195.4% to 757,170 and DALYs increased by 146.1% to 17,128,580, respectively. Meanwhile, the ASIR, ASMR and ASDR showed an upward trend (EAPC of 1.33, 0.94 and 0.42, respectively). The ASIR and ASMR among males were about 2 times more than females, but the increase in ASIR in females (EAPC = 2.24) was more obvious than those in males (EAPC = 0.10) from 2020 to 2030. In China, smoking remained responsible for the highest burden of lung cancer, but the contribution of ambient particulate matter pollution to DALYs increased from 10.6% in 1990 to 22.5% in 2019 in total population. Moreover, we predicted that the number of deaths from lung cancer will increase by 42.7% in China by 2030.ConclusionIn China, the burden of lung cancer has been increasing over the past three decades, which highlights more targeted intervention measures are needed to reduce the burden of lung cancer.

oncology